Staff Publications: September 2017

    1. Alter H, Block TM, Brown N, et al. A Research Agenda for Curing Chronic Hepatitis B Virus Infection. Hepatology. 2017. PMID: 28877549.
    2. Brown PA, Shah B, Fathi A, et al. Nccn Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017. J Natl Compr Canc Netw. 2017;15(9):1091-1102. PMID: 28874594.
    3. Cahn DB, Ristau BT, Ghiraldi EM, et al. Bladder Preservation Therapy: A Review of the Literature and Future Directions. Urology. 2016;96:54-61. PMID: 27257135.
    4. Carroll PR, Parsons JK, Andriole G, et al. Nccn Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016;14(5):509-519. PMID: 27160230.
    5. Churilla TM, Ballman KV, Brown PD, et al. Stereotactic Radiosurgery with or without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2017. PMID: 28939223.
    6. Churilla TM, Handorf E, Collette S, et al. Whole Brain Radiotherapy after Stereotactic Radiosurgery or Surgical Resection among Patients with One to Three Brain Metastases and Favorable Prognoses: A Secondary Analysis of Eortc 22952-26001. Ann Oncol. 2017;28(10):2588-2594. PMID: 28961826.
    7. Clark PE, Spiess PE, Agarwal N, et al. Nccn Guidelines Insights: Bladder Cancer, Version 2.2016. J Natl Compr Canc Netw. 2016;14(10):1213-1224. PMID: 27697976. PMC5379654. NIHMS852988.
    8. de Oliveira JF, Lima TS, Vendramini-Costa DB, et al. Thiosemicarbazones and 4-Thiazolidinones Indole-Based Derivatives: Synthesis, Evaluation of Antiproliferative Activity, Cell Death Mechanisms and Topoisomerase Inhibition Assay. Eur J Med Chem. 2017;136:305-314. PMID: 28505535.
    9. Deng N, Flynn WF, Xia J, et al. Large Scale Free Energy Calculations for Blind Predictions of Protein-Ligand Binding: The D3r Grand Challenge 2015. J Comput Aided Mol Des. 2016;30(9):743-751. PMID: 27562018.
    10. Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 2.2017: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(9):1140-1163.
    11. Dubey B, Jackson M, Zeigler-Johnson C, et al. Inflammation Polymorphisms and Prostate Cancer Risk in Jamaican Men: Role of Obesity/Body Size. Gene. 2017. PMID: 28903065.
    12. Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of Administrative Data for Comparative Effectiveness Research in the Treatment of Non-Prostate Genitourinary Malignancies. Urol Oncol. 2017. PMID: 28867432.
    13. Esposito AC, Crawford J, Sigurdson ER, et al. Omission of Radiotherapy after Breast Conservation Surgery in the Postneoadjuvant Setting. Journal of Surgical Research. 2018;221:49-57.
    14. Finnberg NK, Gokare P, Lev A, et al. Application of 3d Tumoroid Systems to Define Immune and Cytotoxic Therapeutic Responses Based on Tumoroid and Tissue Slice Culture Molecular Signatures. Oncotarget. 2017;8(40):66747-66757.
    15. Fortner RT, Schock H, Jung S, et al. Anti-Mullerian Hormone and Endometrial Cancer: A Multi-Cohort Study. Br J Cancer. 2017. PMID: 28873086.
    16. Ginzburg S, Tomaszewski JJ, Kutikov A. Focal Ablation Therapy for Renal Cancer in the Era of Active Surveillance and Minimally Invasive Partial Nephrectomy. Nat Rev Urol. 2017. PMID: 28895562.
    17. Guitarte C, Grant J, Zhao H, Wang S, Ferriss JS, Hernandez E. Incisional Hernia Formation and Associated Risk Factors on a Gynecologic Oncology Service: An Exploratory Analysis. Arch Gynecol Obstet. 2016;294(4):805-811. PMID: 27101367.
    18. Gupta MK, Tahrir FG, Knezevic T, et al. Grp78 Interacting Partner Bag5 Responds to Er Stress and Protects Cardiomyocytes from Er Stress-Induced Apoptosis. J Cell Biochem. 2016;117(8):1813-1821. PMID: 26729625. PMC4909508. NIHMS778644.
    19. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Post-Operative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2017. PMID: 28941921.
    20. Hayakawa K, Formica AM, Zhou Y, et al. Nlr Nod1 Signaling Promotes Survival of Bcr-Engaged Mature B Cells through up-Regulated Nod1 as a Positive Outcome. J Exp Med. 2017;214(10):3067-3083. PMID: 28878001. PMC5626402.
    21. Herceg Z, Ghantous A, Wild CP, et al. Roadmap for Investigating Epigenome Deregulation and Environmental Origins of Cancer. Int J Cancer. 2017.
    22. Huepenbecker SP, Divine L, Chu CS, Mutch DG. Two Sisters with Mayer-Rokitansky-Kuster-Hauser Syndrome and Serous Adenocarcinoma of the Ovary. Gynecol Oncol Rep. 2017;22:13-15. PMID: 28932808. PMC5596329.
    23. Isoda T, Moore AJ, He Z, et al. Non-Coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate. Cell. 2017;171(1):103-119.e118. PMID: 28938112. PMC5621651. NIHMS904268.
    24. Jain R, Dotan E. Nutrition and Aging: A Practicing Oncologist’s Perspective. Curr Oncol Rep. 2017;19(11):71. PMID: 28884400.
    25. Jordan SE, Micaily I, Hernandez E, et al. Image-Guided High-Dose-Rate Intracavitary Brachytherapy in the Treatment of Medically Inoperable Early-Stage Endometrioid Type Endometrial Adenocarcinoma. Brachytherapy. 2017. PMID: 28958736.
    26. Jung S, Allen N, Arslan AA, et al. Anti-Mullerian Hormone and Risk of Ovarian Cancer in Nine Cohorts. Int J Cancer. 2017. PMID: 28921520.
    27. Krais JJ, Virani N, McKernan PH, et al. Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Molecular Cancer Therapeutics. 2017;16(9):1855-1865.
    28. Lev A, Deihimi S, Shagisultanova E, et al. Preclinical Rationale for Combination of Crizotinib with Mitomycin C for the Treatment of Advanced Colorectal Cancer. Cancer Biol Ther. 2017:1-11. PMID: 28886275.
    29. Lu H, Liu S, Zhang G, et al. Pak Signalling Drives Acquired Drug Resistance to Mapk Inhibitors in Braf-Mutant Melanomas. Nature. 2017;550(7674):133-136. PMID: 28953887.
    30. Merza H, Bilusic M. Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions. Curr Oncol Rep. 2017;19(4):27. PMID: 28303494.
    31. Moore MD, Daly JM. The Evolution of Oncology Clinical Research: Lessons Learned. Surg Oncol Clin N Am. 2017;26(4):xvii-xx. PMID: 28923234.
    32. Mortazavi SMJ. Comments on “Study of Bacterial Contamination of Mobile Phones and Stethoscopes in Neonatal Intensive Care Unit”. International Journal of Pediatrics. 2017;5(11):6143-6144.
    33. Mortazavi SMJ. Re: Are Electromagnetic Fields in Incubators a Risk Factor for Autism? Acta Paediatr. 2017. PMID: 28862780.
    34. Ndoye A, Budina-Kolomets A, Kugel CH, et al. Atg5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. Cancer Res. 2017. PMID: 28887323.
    35. Pal RK, Haider K, Kaur D, et al. A Combined Treatment of Hydration and Dynamical Effects for the Modeling of Host-Guest Binding Thermodynamics: The Sampl5 Blinded Challenge. J Comput Aided Mol Des. 2017;31(1):29-44. PMID: 27696239. PMC5477994. NIHMS864064.
    36. Parker DC, Handorf E, Smaldone MC, Uzzo RG, Pitt H, Reese AC. Race and Postoperative Complications Following Urologic Cancer Surgery: An Acs-Nsqip Analysis. Urol Oncol. 2017. PMID: 28867431.
    37. Ramos JD, Wingate JT, Gulati R, et al. Venous Thromboembolism Risk in Patients with Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer. 2017. PMID: 28923700.
    38. Reck M, Paz-Ares L, Bidoli P, et al. Outcomes in Patients with Aggressive or Refractory Disease from Revel: A Randomized Phase Iii Study of Docetaxel with Ramucirumab or Placebo for Second-Line Treatment of Stage Iv Non-Small-Cell Lung Cancer. Lung Cancer. 2017;112:181-187.
    39. Ribas A, Dummer R, Puzanov I, et al. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-Pd-1 Immunotherapy. Cell. 2017;170(6):1109-1119.e1110. PMID: 28886381.
    40. Rossiter SE, Fletcher MH, Wuest WM. Natural Products as Platforms to Overcome Antibiotic Resistance. Chem Rev. 2017. PMID: 28953368.
    41. Shore ND, Dinney C, Uzzo R. The Society of Urologic Oncology Clinical Trials Consortium: A Brief History and Overview. Rev Urol. 2017;19(2):122-124. PMID: 28959150. PMC5610363.
    42. Sigurdson ER. Preface. Surg Oncol Clin N Am. 2017;26(4):xv-xvi. PMID: 28923233.
    43. Ward JM, Schmalenberg K, Antonishyn NA, et al. Human Papillomavirus Genotype Distribution in Cervical Samples among Vaccine Naive Barbados Women. Cancer Causes Control. 2017. PMID: 28913693.
    44. Werlang ME, Lewis MD, Bartel MJ. Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis. ACG Case Rep J. 2017;4:e103. PMID: 28879208. PMC5577046.
    45. Wu D, Si M, Xue HY, Wong HL. Nanomedicine Applications in the Treatment of Breast Cancer: Current State of the Art. Int J Nanomedicine. 2017;12:5879-5892. PMID: 28860754. PMC5566389.
    46. Zhang BW, Deng N, Tan Z, Levy RM. Stratified Uwham and Its Stochastic Approximation for Multicanonical Simulations Which Are Far from Equilibrium. J Chem Theory Comput. 2017. PMID: 28902500.

     

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s